Share Price and Basic Stock Data
Last Updated: December 26, 2025, 11:11 pm
| PEG Ratio | -3.83 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Dhanvantri Jeevan Rekha Ltd operates in the Hospitals & Medical Services industry, focusing on healthcare delivery. As of the latest reporting, the company’s share price stood at ₹25.0, with a market capitalization of ₹10.3 Cr. Over the past fiscal years, Dhanvantri has shown a fluctuating revenue trend. Sales reported for the fiscal year ending March 2023 were ₹17.68 Cr, up from ₹16.77 Cr in the previous year. The trailing twelve months (TTM) revenue rose to ₹22.88 Cr, indicating a positive trajectory. Quarterly sales have also shown variability, with ₹5.44 Cr recorded in March 2024, reflecting an upward trend from ₹4.96 Cr in March 2023. However, the operating profit margin (OPM) has faced challenges, recording -1.20% in the latest quarter, indicating ongoing operational inefficiencies. The company’s ability to stabilize revenues will depend on improving its operational metrics and managing expenses effectively, which stood at ₹17.10 Cr in March 2023, slightly lower than the previous year’s ₹15.27 Cr.
Profitability and Efficiency Metrics
The profitability of Dhanvantri Jeevan Rekha Ltd remains under pressure, as evidenced by its negative net profit margins in several quarters. The net profit for the year ending March 2023 was reported at ₹-0.22 Cr, a stark contrast to the ₹0.49 Cr profit recorded in March 2022. The company’s return on equity (ROE) was reported at 5.20%, while return on capital employed (ROCE) stood at 5.82%, both lower than industry averages, signaling a need for improved capital efficiency. The interest coverage ratio (ICR) was remarkably high at 91.29x, indicating that the company has no debt obligations to service, which is a strength. However, the operating profit has been volatile, with OPM fluctuating from a high of 9.13% in December 2023 to a low of -1.20% recently. The cash conversion cycle (CCC) of 29.01 days is a moderate figure, suggesting that while the company efficiently manages its receivables, there is room for improvement in inventory and payables management.
Balance Sheet Strength and Financial Ratios
Dhanvantri Jeevan Rekha Ltd’s balance sheet reflects a conservative financial structure with no borrowings, a significant strength that positions the company favorably against competitors that may carry debt. The reserves as of March 2025 stood at ₹5.98 Cr, an increase from ₹5.15 Cr in March 2023, indicating a gradual strengthening of the company’s equity base. The asset turnover ratio, reported at 1.52, suggests efficient use of assets to generate revenue, although this figure is in line with sector norms. The price-to-book value (P/BV) ratio of 0.84x indicates that the stock is trading below its book value, potentially making it an attractive investment. The current ratio of 1.49x and quick ratio of 1.44x further reinforce the company’s liquidity position, allowing it to cover short-term liabilities comfortably. However, the operating profit margin’s decline points toward challenges in controlling operational costs, which could impact future profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Dhanvantri Jeevan Rekha Ltd reveals a stable but concentrated ownership structure, with promoters holding 19.65% of the company, while the public holds 80.35%. The total number of shareholders as of September 2025 was reported at 1,665, reflecting a slight increase from 1,416 in December 2022. This growth in shareholder numbers indicates increasing interest among retail investors, although the lack of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) suggests limited institutional confidence. The consistent promoter holding signals stability in management, which can be a positive factor for potential investors. However, the lack of institutional backing could be a concern, as institutions often provide a level of credibility and stability to a company’s stock. The market capitalization of ₹10.3 Cr and a high P/E ratio of 103 also indicate that the stock might be perceived as overvalued compared to its earnings, which could deter value-focused investors.
Outlook, Risks, and Final Insight
The outlook for Dhanvantri Jeevan Rekha Ltd hinges on its ability to improve operational efficiencies and profitability amidst a competitive landscape. Key strengths include a strong liquidity position with no debt and a growing reserve base, which could support future expansion or operational improvements. However, persistent challenges in achieving positive net profits and managing operating expenses pose risks to the company’s financial health. The volatility in both revenue and profitability metrics suggests that the company must enhance its operational strategies to stabilize its financial performance. The absence of institutional investors may limit the stock’s appeal, and if the company fails to deliver consistent profits, it risks losing investor confidence. In a favorable scenario where operational efficiencies improve and expenses are controlled, the company could see a resurgence in profitability, enhancing its attractiveness to both retail and institutional investors. Conversely, continued losses could lead to further declines in market confidence, impacting its share price negatively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| NG Industries Ltd | 51.4 Cr. | 154 | 187/120 | 10.5 | 117 | 2.28 % | 23.6 % | 20.7 % | 10.0 |
| Global Longlife Hospital and Research Ltd | 24.1 Cr. | 23.0 | 35.5/15.5 | 24.3 | 0.00 % | 13.7 % | 17.7 % | 10.0 | |
| Gian Lifecare Ltd | 9.04 Cr. | 8.74 | 20.8/7.08 | 100 | 19.1 | 0.00 % | 3.00 % | 0.81 % | 10.0 |
| Fortis Malar Hospitals Ltd | 113 Cr. | 60.1 | 98.7/55.2 | 24.9 | 18.3 | 0.00 % | 0.83 % | 0.56 % | 10.0 |
| Family Care Hospitals Ltd | 20.1 Cr. | 3.72 | 6.94/3.40 | 1.51 | 0.00 % | 79.2 % | 85.5 % | 10.0 | |
| Industry Average | 26,425.21 Cr | 698.61 | 93.39 | 93.18 | 0.32% | 15.48% | 14.81% | 9.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.97 | 4.65 | 4.96 | 4.98 | 4.90 | 5.15 | 5.44 | 5.70 | 5.42 | 5.70 | 5.83 | 5.51 | 5.84 |
| Expenses | 4.04 | 4.48 | 4.73 | 4.75 | 4.87 | 4.68 | 5.43 | 5.45 | 5.18 | 5.51 | 5.79 | 5.37 | 5.91 |
| Operating Profit | -0.07 | 0.17 | 0.23 | 0.23 | 0.03 | 0.47 | 0.01 | 0.25 | 0.24 | 0.19 | 0.04 | 0.14 | -0.07 |
| OPM % | -1.76% | 3.66% | 4.64% | 4.62% | 0.61% | 9.13% | 0.18% | 4.39% | 4.43% | 3.33% | 0.69% | 2.54% | -1.20% |
| Other Income | 0.05 | 0.08 | 0.06 | 0.06 | 0.07 | 0.09 | 0.07 | 0.08 | 0.10 | 0.13 | 0.11 | 0.07 | 0.09 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.24 | 0.23 | 0.23 | 0.24 | 0.25 | 0.20 | 0.18 | 0.17 | 0.16 | 0.17 | 0.07 | 0.15 | 0.16 |
| Profit before tax | -0.26 | 0.02 | 0.06 | 0.05 | -0.15 | 0.36 | -0.10 | 0.16 | 0.17 | 0.15 | 0.08 | 0.06 | -0.14 |
| Tax % | 0.00% | 0.00% | 133.33% | 0.00% | 0.00% | 0.00% | -10.00% | 0.00% | 0.00% | 0.00% | 62.50% | 0.00% | 0.00% |
| Net Profit | -0.26 | 0.02 | -0.02 | 0.05 | -0.15 | 0.36 | -0.09 | 0.16 | 0.17 | 0.15 | 0.03 | 0.06 | -0.14 |
| EPS in Rs | -0.63 | 0.05 | -0.05 | 0.12 | -0.37 | 0.88 | -0.22 | 0.39 | 0.41 | 0.37 | 0.07 | 0.15 | -0.34 |
Last Updated: December 27, 2025, 7:01 am
Below is a detailed analysis of the quarterly data for Dhanvantri Jeevan Rekha Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 5.84 Cr.. The value appears strong and on an upward trend. It has increased from 5.51 Cr. (Jun 2025) to 5.84 Cr., marking an increase of 0.33 Cr..
- For Expenses, as of Sep 2025, the value is 5.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.37 Cr. (Jun 2025) to 5.91 Cr., marking an increase of 0.54 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.07 Cr.. The value appears to be declining and may need further review. It has decreased from 0.14 Cr. (Jun 2025) to -0.07 Cr., marking a decrease of 0.21 Cr..
- For OPM %, as of Sep 2025, the value is -1.20%. The value appears to be declining and may need further review. It has decreased from 2.54% (Jun 2025) to -1.20%, marking a decrease of 3.74%.
- For Other Income, as of Sep 2025, the value is 0.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.07 Cr. (Jun 2025) to 0.09 Cr., marking an increase of 0.02 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.15 Cr. (Jun 2025) to 0.16 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Jun 2025) to -0.14 Cr., marking a decrease of 0.20 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Jun 2025) to -0.14 Cr., marking a decrease of 0.20 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.34. The value appears to be declining and may need further review. It has decreased from 0.15 (Jun 2025) to -0.34, marking a decrease of 0.49.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:51 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.26 | 7.97 | 9.26 | 11.16 | 13.74 | 16.84 | 18.21 | 9.78 | 16.77 | 17.68 | 20.46 | 22.65 | 22.88 |
| Expenses | 5.93 | 6.44 | 7.81 | 9.53 | 11.89 | 15.61 | 17.55 | 10.53 | 15.27 | 17.10 | 19.62 | 21.93 | 22.58 |
| Operating Profit | 1.33 | 1.53 | 1.45 | 1.63 | 1.85 | 1.23 | 0.66 | -0.75 | 1.50 | 0.58 | 0.84 | 0.72 | 0.30 |
| OPM % | 18.32% | 19.20% | 15.66% | 14.61% | 13.46% | 7.30% | 3.62% | -7.67% | 8.94% | 3.28% | 4.11% | 3.18% | 1.31% |
| Other Income | 0.21 | 0.44 | 0.31 | -0.11 | 0.14 | 0.12 | 0.16 | 0.18 | 0.21 | 0.24 | 0.29 | 0.41 | 0.40 |
| Interest | 0.01 | 0.08 | 0.08 | 0.18 | 0.22 | 0.11 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Depreciation | 0.67 | 0.36 | 0.27 | 0.37 | 1.10 | 1.13 | 1.10 | 1.04 | 1.02 | 0.96 | 0.87 | 0.56 | 0.55 |
| Profit before tax | 0.86 | 1.53 | 1.41 | 0.97 | 0.67 | 0.11 | -0.32 | -1.63 | 0.67 | -0.15 | 0.25 | 0.56 | 0.15 |
| Tax % | 39.53% | 29.41% | 32.62% | 43.30% | -7.46% | 63.64% | -15.62% | -12.88% | 28.36% | 46.67% | 36.00% | 8.93% | |
| Net Profit | 0.52 | 1.07 | 0.95 | 0.55 | 0.73 | 0.05 | -0.26 | -1.42 | 0.49 | -0.22 | 0.17 | 0.51 | 0.10 |
| EPS in Rs | 1.27 | 2.61 | 2.32 | 1.34 | 1.78 | 0.12 | -0.63 | -3.46 | 1.20 | -0.54 | 0.41 | 1.24 | 0.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 105.77% | -11.21% | -42.11% | 32.73% | -93.15% | -620.00% | -446.15% | 134.51% | -144.90% | 177.27% | 200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -116.98% | -30.89% | 74.83% | -125.88% | -526.85% | 173.85% | 580.66% | -279.41% | 322.17% | 22.73% |
Dhanvantri Jeevan Rekha Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 4% |
| 3 Years: | 11% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 32% |
| 3 Years: | 1% |
| TTM: | 46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 26% |
| 3 Years: | 16% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | 2% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 3:11 pm
Balance Sheet
Last Updated: December 4, 2025, 2:44 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 |
| Reserves | 2.50 | 4.29 | 5.25 | 5.79 | 6.52 | 6.57 | 6.30 | 4.88 | 5.37 | 5.15 | 5.32 | 5.98 | 5.90 |
| Borrowings | 0.09 | 0.00 | 0.00 | 1.94 | 1.95 | 0.10 | 0.10 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.70 | 2.52 | 3.29 | 4.53 | 3.79 | 4.53 | 4.30 | 4.76 | 4.84 | 4.56 | 5.55 | 4.65 | 5.66 |
| Total Liabilities | 8.44 | 10.96 | 12.69 | 16.41 | 16.41 | 15.35 | 14.85 | 13.86 | 14.36 | 13.86 | 15.02 | 14.78 | 15.71 |
| Fixed Assets | 4.57 | 5.05 | 7.80 | 12.07 | 12.28 | 11.44 | 10.68 | 9.72 | 8.85 | 8.54 | 8.14 | 8.41 | 8.80 |
| CWIP | 0.00 | 1.44 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 3.87 | 4.47 | 4.89 | 4.34 | 4.13 | 3.79 | 4.17 | 4.14 | 5.51 | 5.32 | 6.88 | 6.37 | 6.91 |
| Total Assets | 8.44 | 10.96 | 12.69 | 16.41 | 16.41 | 15.35 | 14.85 | 13.86 | 14.36 | 13.86 | 15.02 | 14.78 | 15.71 |
Below is a detailed analysis of the balance sheet data for Dhanvantri Jeevan Rekha Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.15 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.15 Cr..
- For Reserves, as of Sep 2025, the value is 5.90 Cr.. The value appears to be declining and may need further review. It has decreased from 5.98 Cr. (Mar 2025) to 5.90 Cr., marking a decrease of 0.08 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.66 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.65 Cr. (Mar 2025) to 5.66 Cr., marking an increase of 1.01 Cr..
- For Total Liabilities, as of Sep 2025, the value is 15.71 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.78 Cr. (Mar 2025) to 15.71 Cr., marking an increase of 0.93 Cr..
- For Fixed Assets, as of Sep 2025, the value is 8.80 Cr.. The value appears strong and on an upward trend. It has increased from 8.41 Cr. (Mar 2025) to 8.80 Cr., marking an increase of 0.39 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 6.91 Cr.. The value appears strong and on an upward trend. It has increased from 6.37 Cr. (Mar 2025) to 6.91 Cr., marking an increase of 0.54 Cr..
- For Total Assets, as of Sep 2025, the value is 15.71 Cr.. The value appears strong and on an upward trend. It has increased from 14.78 Cr. (Mar 2025) to 15.71 Cr., marking an increase of 0.93 Cr..
Notably, the Reserves (5.90 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.24 | 1.53 | 1.45 | -0.31 | -0.10 | 1.13 | 0.56 | -0.82 | 1.50 | 0.58 | 0.84 | 0.72 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16.09 | 15.11 | 20.50 | 11.45 | 17.80 | 22.32 | 9.02 | 39.93 | 37.22 | 50.58 | 31.22 | 29.01 |
| Inventory Days | 11.70 | 17.77 | 11.99 | |||||||||
| Days Payable | 0.00 | 0.00 | 0.00 | |||||||||
| Cash Conversion Cycle | 16.09 | 15.11 | 20.50 | 11.45 | 29.50 | 40.09 | 21.00 | 39.93 | 37.22 | 50.58 | 31.22 | 29.01 |
| Working Capital Days | 68.37 | 66.86 | 56.76 | -35.32 | -26.83 | -17.34 | -32.27 | -53.37 | -25.47 | -3.10 | -32.29 | -16.60 |
| ROCE % | 14.04% | 19.76% | 16.70% | 14.94% | 7.27% | 1.88% | -2.62% | -16.39% | 7.41% | -1.49% | 2.77% | 5.82% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.60 | 0.40 | -0.53 | 0.01 | -3.47 |
| Diluted EPS (Rs.) | 1.60 | 0.40 | -0.53 | 0.01 | -3.47 |
| Cash EPS (Rs.) | 2.58 | 2.48 | 1.78 | 3.63 | -0.91 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 24.39 | 22.81 | 22.41 | 22.93 | 21.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 24.39 | 22.81 | 22.41 | 22.93 | 21.75 |
| Revenue From Operations / Share (Rs.) | 54.53 | 49.26 | 42.58 | 40.38 | 23.55 |
| PBDIT / Share (Rs.) | 2.73 | 2.71 | 1.97 | 4.11 | -1.36 |
| PBIT / Share (Rs.) | 1.37 | 0.62 | -0.33 | 1.66 | -3.87 |
| PBT / Share (Rs.) | 1.34 | 0.61 | -0.34 | 1.62 | -3.92 |
| Net Profit / Share (Rs.) | 1.22 | 0.39 | -0.52 | 1.18 | -3.43 |
| PBDIT Margin (%) | 5.00 | 5.51 | 4.62 | 10.17 | -5.76 |
| PBIT Margin (%) | 2.50 | 1.27 | -0.77 | 4.11 | -16.44 |
| PBT Margin (%) | 2.45 | 1.24 | -0.81 | 4.01 | -16.66 |
| Net Profit Margin (%) | 2.23 | 0.80 | -1.22 | 2.92 | -14.55 |
| Return on Networth / Equity (%) | 4.99 | 1.74 | -2.32 | 5.14 | -15.75 |
| Return on Capital Employeed (%) | 4.85 | 2.33 | -1.25 | 5.69 | -16.04 |
| Return On Assets (%) | 3.42 | 1.10 | -1.56 | 3.41 | -11.11 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Asset Turnover Ratio (%) | 1.52 | 1.42 | 1.25 | 1.23 | 0.71 |
| Current Ratio (X) | 1.49 | 1.30 | 1.24 | 1.66 | 0.74 |
| Quick Ratio (X) | 1.44 | 1.27 | 1.19 | 1.61 | 0.71 |
| Inventory Turnover Ratio (X) | 163.30 | 0.00 | 0.00 | 0.00 | 23.45 |
| Interest Coverage Ratio (X) | 91.29 | 224.14 | 117.93 | 104.40 | -26.69 |
| Interest Coverage Ratio (Post Tax) (X) | 41.79 | 33.85 | -30.24 | 30.99 | -66.31 |
| Enterprise Value (Cr.) | 6.04 | 7.20 | 4.55 | 5.13 | 2.26 |
| EV / Net Operating Revenue (X) | 0.26 | 0.35 | 0.25 | 0.30 | 0.23 |
| EV / EBITDA (X) | 5.33 | 6.38 | 5.56 | 3.01 | -4.01 |
| MarketCap / Net Operating Revenue (X) | 0.37 | 0.49 | 0.30 | 0.41 | 0.31 |
| Price / BV (X) | 0.84 | 1.07 | 0.58 | 0.72 | 0.34 |
| Price / Net Operating Revenue (X) | 0.37 | 0.49 | 0.30 | 0.41 | 0.31 |
| EarningsYield | 0.05 | 0.01 | -0.04 | 0.07 | -0.45 |
After reviewing the key financial ratios for Dhanvantri Jeevan Rekha Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 5. It has increased from 0.40 (Mar 24) to 1.60, marking an increase of 1.20.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 5. It has increased from 0.40 (Mar 24) to 1.60, marking an increase of 1.20.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.58. This value is below the healthy minimum of 3. It has increased from 2.48 (Mar 24) to 2.58, marking an increase of 0.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.39. It has increased from 22.81 (Mar 24) to 24.39, marking an increase of 1.58.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.39. It has increased from 22.81 (Mar 24) to 24.39, marking an increase of 1.58.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 54.53. It has increased from 49.26 (Mar 24) to 54.53, marking an increase of 5.27.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.73. This value is within the healthy range. It has increased from 2.71 (Mar 24) to 2.73, marking an increase of 0.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.37. This value is within the healthy range. It has increased from 0.62 (Mar 24) to 1.37, marking an increase of 0.75.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.34. This value is within the healthy range. It has increased from 0.61 (Mar 24) to 1.34, marking an increase of 0.73.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has increased from 0.39 (Mar 24) to 1.22, marking an increase of 0.83.
- For PBDIT Margin (%), as of Mar 25, the value is 5.00. This value is below the healthy minimum of 10. It has decreased from 5.51 (Mar 24) to 5.00, marking a decrease of 0.51.
- For PBIT Margin (%), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 10. It has increased from 1.27 (Mar 24) to 2.50, marking an increase of 1.23.
- For PBT Margin (%), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 10. It has increased from 1.24 (Mar 24) to 2.45, marking an increase of 1.21.
- For Net Profit Margin (%), as of Mar 25, the value is 2.23. This value is below the healthy minimum of 5. It has increased from 0.80 (Mar 24) to 2.23, marking an increase of 1.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 15. It has increased from 1.74 (Mar 24) to 4.99, marking an increase of 3.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has increased from 2.33 (Mar 24) to 4.85, marking an increase of 2.52.
- For Return On Assets (%), as of Mar 25, the value is 3.42. This value is below the healthy minimum of 5. It has increased from 1.10 (Mar 24) to 3.42, marking an increase of 2.32.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.52. It has increased from 1.42 (Mar 24) to 1.52, marking an increase of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.49. This value is below the healthy minimum of 1.5. It has increased from 1.30 (Mar 24) to 1.49, marking an increase of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from 1.27 (Mar 24) to 1.44, marking an increase of 0.17.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 163.30. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 163.30, marking an increase of 163.30.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 91.29. This value is within the healthy range. It has decreased from 224.14 (Mar 24) to 91.29, marking a decrease of 132.85.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 41.79. This value is within the healthy range. It has increased from 33.85 (Mar 24) to 41.79, marking an increase of 7.94.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6.04. It has decreased from 7.20 (Mar 24) to 6.04, marking a decrease of 1.16.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has decreased from 0.35 (Mar 24) to 0.26, marking a decrease of 0.09.
- For EV / EBITDA (X), as of Mar 25, the value is 5.33. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 5.33, marking a decrease of 1.05.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.49 (Mar 24) to 0.37, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.07 (Mar 24) to 0.84, marking a decrease of 0.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.49 (Mar 24) to 0.37, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.05, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dhanvantri Jeevan Rekha Ltd:
- Net Profit Margin: 2.23%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.85% (Industry Average ROCE: 15.48%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.99% (Industry Average ROE: 14.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 41.79
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 103 (Industry average Stock P/E: 93.39)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.23%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | 1, Saket, Meerut Uttar Pradesh 250003 | dhanvantrihospital@gmail.com http://www.dhanvantrihospital.in |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Shalini Sharma | Managing Director |
| Mr. Premjit Singh Kashyap | Director |
| Mrs. Meenaakshi Elhence | Director |
| Mr. Tulsi Prasad Sharma | Director |
| Dr. Anil Elhence | Director |
| Mrs. Rowena Sharma | Director |
| Mr. Mohd Harris | Independent Director |
| Mr. Amitabh Krishna Bhatia | Independent Director |
| Mr. Ravi Karan | Independent Director |
FAQ
What is the intrinsic value of Dhanvantri Jeevan Rekha Ltd?
Dhanvantri Jeevan Rekha Ltd's intrinsic value (as of 02 January 2026) is ₹107.08 which is 328.32% higher the current market price of ₹25.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹10.3 Cr. market cap, FY2025-2026 high/low of ₹35.9/16.5, reserves of ₹5.90 Cr, and liabilities of ₹15.71 Cr.
What is the Market Cap of Dhanvantri Jeevan Rekha Ltd?
The Market Cap of Dhanvantri Jeevan Rekha Ltd is 10.3 Cr..
What is the current Stock Price of Dhanvantri Jeevan Rekha Ltd as on 02 January 2026?
The current stock price of Dhanvantri Jeevan Rekha Ltd as on 02 January 2026 is ₹25.0.
What is the High / Low of Dhanvantri Jeevan Rekha Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dhanvantri Jeevan Rekha Ltd stocks is ₹35.9/16.5.
What is the Stock P/E of Dhanvantri Jeevan Rekha Ltd?
The Stock P/E of Dhanvantri Jeevan Rekha Ltd is 103.
What is the Book Value of Dhanvantri Jeevan Rekha Ltd?
The Book Value of Dhanvantri Jeevan Rekha Ltd is 24.5.
What is the Dividend Yield of Dhanvantri Jeevan Rekha Ltd?
The Dividend Yield of Dhanvantri Jeevan Rekha Ltd is 0.00 %.
What is the ROCE of Dhanvantri Jeevan Rekha Ltd?
The ROCE of Dhanvantri Jeevan Rekha Ltd is 5.82 %.
What is the ROE of Dhanvantri Jeevan Rekha Ltd?
The ROE of Dhanvantri Jeevan Rekha Ltd is 5.20 %.
What is the Face Value of Dhanvantri Jeevan Rekha Ltd?
The Face Value of Dhanvantri Jeevan Rekha Ltd is 10.0.